BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Sep 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-03

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-04	Bio-Rad A Common Stock	M	2600	—	Acquired	415162	Direct
2019-09-04	Bio-Rad A Common Stock	F	1290	$335.20	Disposed	413872	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-03	Restricted Stock Units	$0	A	11597	Acquired		Bio-Rad A Common Stock (11597)	Direct
2019-09-03	Non-Qualified Stock Option (right to buy)	$333.34	A	11597	Acquired	2029-09-03	Bio-Rad A Common Stock (11597)	Direct
2019-09-04	Restricted Stock Units	$0	M	2600	Disposed		Bio-Rad A Common Stock (2600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad B Common Stock	12771	Indirect
Bio-Rad B Common Stock	4060054	Indirect
Bio-Rad B Common Stock	275809	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F5: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F6: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F7: The restricted stock units vest in five equal annual installments beginning September 4, 2019.